黑料网

Biography

Michael R Hamblin Ph.D. is a Principal Investigator at the Wellman Center for Photomedicine at Massachusetts General Hospital, an Associate Professor of Dermatology at Harvard Medical School and is a member of the affiliated faculty of the Harvard-MIT Division of Health Science and Technology. He was trained as a synthetic organic chemist and received his PhD from Trent University in England.He directs a laboratory of around a dozen post-doctoral fellows, visiting scientists and graduate students. His research program is supported by NIH, CDMRP, USAFOSR and CIMIT among other funding agencies. He has published 168 peer-reviewed articles, over 150 conference proceedings, book chapters and International abstracts and holds 8 patents. He is Associate Editor for 5 journals and serves on NIH Study Sections. For the past seven years Dr Hamblin has chaired an annual conference at SPIE Photonics West entitled Mechanisms for low level light therapy and he has edited the seven proceedings volumes together with two other major textbooks on PDT. In 2011 Dr Hamblin was honored by election as a Fellow of SPIE.

Research Interest

Photodynamic therapy (PDT) for infections, cancer, and heart disease and in low-level light therapy (LLLT) for wound healing, arthritis, traumatic brain injury and hair regrowth.

Certificate

Global Speakers in the subject

Global Experts in the subject

Publications

Photodynamic Therapy as an Emerging Treatment Modality for Cancer and Non-Cancer Diseases

Zhiwei Hu, Nancy Oleinick and Michael R Hamblin

Editorial: J Anal Bioanal Tech 2014, S1:e001

DOI: